Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.01772, expectations were $-0.03. Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 ...
Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...
Thursday, Feb. 26, 2026 at 8:30 a.m. ET Craig Collard, Chief Executive Officer; Ira Duarte, Executive Vice President and Chief Financial Officer; Bill Forbes, Executive Vice President and Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results